This is a demo store. No orders will be fulfilled.

Muromonab (anti-CD3)

    应用:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
  • 宿主种属: 小鼠(Mouse)
  • 种属反应性: 人(Human)
  • 亚型: Mouse IgG2a
  • 偶联: Unconjugated
有货

库存信息

关闭

库存信息

关闭

库存信息

关闭

库存信息

关闭
货号 (SKU) 包装规格 是否现货 价格 数量
Ab170491-100μg
100μg 现货 Stock Image
Ab170491-1mg
1mg 现货 Stock Image
Ab170491-5mg
5mg 现货 Stock Image
Ab170491-10mg
10mg 期货 Stock Image

基本信息

产品名称 Muromonab (anti-CD3)
别名 莫罗单抗 | CD3抗体 | CD3单克隆抗体 | CD3药靶抗体 | CD3E抗体 | CD3E单克隆抗体 | CD3E药靶抗体
英文别名 CD_antigen: CD3e | CD3 antigen, delta subunit | CD3 | CD3d antigen | CD3d antigen, delta polypeptide (TiT3 complex) | CD3d molecule, delta (CD3-TCR complex) | CD3-DELTA | CD3e antigen | CD3e antigen, epsilon polypeptide (TiT3 complex) | CD3e molecule, eps
规格或纯度 无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
生化机理 The CD3 complex mediates signal transduction.
宿主种属 小鼠(Mouse)
特异性 CD3
应用 ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR)
种属反应性 人(Human)
偶联 Unconjugated

产品属性

抗体类型 Primary antibody
克隆类型 重组抗体
Format Whole IgG
亚型 Mouse IgG2a
轻链亚型 kappa
SDS-PAGE 146.34 kDa
纯化方法 Protein A purified
纯度 >95%
来源 CHO supernatant
物理外观 Liquid
储存缓冲液 Supplied as a 0.22 μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂 No
浓度 见COA
储存温度 -80℃储存,避免反复冻融
运输条件 超低温冰袋运输
稳定性与储存 长期储存-80℃(24个月);收货后建议分装,避免反复冻融。
CAS编号和信息 140608-64-6
分子类型 抗体

关联靶点(人)

CD3E Tclin 细胞表面糖蛋白 CD3 ε 链(T-cell surface glycoprotein CD3 epsilon chain) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
CD3E Tclin T-cell surface glycoprotein CD3 epsilon chain (0 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID

作用机制

作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献

图片

Muromonab (anti-CD3) (Ab170491) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD3 with Muromonab (anti-CD3) (Ab170491) (right panel) conjugated with biotin compared with Human IgG (Ab170213) conjugated with biotin - Isotype Control (left panel) and detected with SA-PE (rp156150).

Muromonab (anti-CD3) (Ab170491) - Flow Cytometry
Flow Cytometry analysis of human peripheral blood lymphocytes labelling CD3 (red) with Muromonab (anti-CD3) (Ab170491) conjugated with biotin and detected with SA-PE (rp156150). Blue - Isotype control, human IgG (Ab170213) conjugated with biotin. Black - Unlabelled control, cells without incubation with primary antibody.

Muromonab (anti-CD3) (Ab170491) - Flow Cytometry
Flow Cytometry analysis of Jurkat cells labelling CD3 (red) with Muromonab (anti-CD3) (Ab170491). Goat Anti-Human IgG (FITC) (Ab175834) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Muromonab (anti-CD3) (Ab170491) - SEC
The purity of Muromonab (anti-CD3) (Ab170491) is more than 95% verified by HPLC.

质检证书(CoA,COO,BSE/TSE 和分析图谱)

C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到3个结果

批号(Lot Number) 证书类型 货号
ZJ23F1001371 分析证书 Ab170491
ZJ23F1001372 分析证书 Ab170491
ZJ24F0708072 分析证书 Ab170491

可替换产品

引用文献

1. Linke R, Klein A, Seimetz D.  (2010)  Catumaxomab: clinical development and future directions..  MAbs,  (2): (129-36).  [PMID:20190561]
2. Soudais C, de Villartay JP, Le Deist F, Fischer A, Lisowska-Grospierre B.  (1993)  Independent mutations of the human CD3-epsilon gene resulting in a T cell receptor/CD3 complex immunodeficiency..  Nat Genet,  (1): (77-81).  [PMID:8490660]
3. de Saint Basile G, Geissmann F, Flori E, Uring-Lambert B, Soudais C, Cavazzana-Calvo M, Durandy A, Jabado N, Fischer A, Le Deist F.  (2004)  Severe combined immunodeficiency caused by deficiency in either the delta or the epsilon subunit of CD3..  J Clin Invest,  114  (10): (1512-7).  [PMID:15546002]
4. Mathur D, Root AR, Bugaj-Gaweda B, Bisulco S, Tan X, Fang W, Kearney JC, Lucas J, Guffroy M, Golas J et al..  (2020)  A Novel GUCY2C-CD3 T-Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers..  Clin Cancer Res,  26  (9): (2188-2202).  [PMID:31996389]
5. Borroto A, Reyes-Garau D, Jiménez MA, Carrasco E, Moreno B, Martínez-Pasamar S, Cortés JR, Perona A, Abia D, Blanco S et al..  (2016)  First-in-class inhibitor of the T cell receptor for the treatment of autoimmune diseases..  Sci Transl Med,  (370): (370ra184).  [PMID:28003549]
6. Sun LL, Ellerman D, Mathieu M, Hristopoulos M, Chen X, Li Y, Yan X, Clark R, Reyes A, Stefanich E et al..  (2015)  Anti-CD20/CD3 T cell-dependent bispecific antibody for the treatment of B cell malignancies..  Sci Transl Med,  (287): (287ra70).  [PMID:25972002]
7. Lanier, L L LL, Chang, C C, Spits, H H and Phillips, J H JH..  (1992)  Expression of cytoplasmic CD3 epsilon proteins in activated human adult natural killer (NK) cells and CD3 gamma, delta, epsilon complexes in fetal NK cells. Implications for the relationship of NK and T lymphocytes..  Journal of immunology (Baltimore, Md. : 1950),  (15): [PMID:1387664]
8. Barber, E K EK, Dasgupta, J D JD, Schlossman, S F SF, Trevillyan, J M JM and Rudd, C E CE..  (1989)  The CD4 and CD8 antigens are coupled to a protein-tyrosine kinase (p56lck) that phosphorylates the CD3 complex..  Proceedings of the National Academy of Sciences of the United States of America,  [PMID:2470098]
9. Gold, D P DP and 6 more authors..  (1986)  Isolation of cDNA clones encoding the 20K non-glycosylated polypeptide chain of the human T-cell receptor/T3 complex..  Nature,  [PMID:3012357]
10. Salomon, Arthur R AR and 10 more authors..  (2003)  Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry..  Proceedings of the National Academy of Sciences of the United States of America,  (21): [PMID:12522270]
11. Brill, Laurence M LM and 5 more authors..  (2004)  Robust phosphoproteomic profiling of tyrosine phosphorylation sites from human T cells using immobilized metal affinity chromatography and tandem mass spectrometry..  Analytical chemistry,  (15): [PMID:15144186]
12. Gimferrer, Idoia I and 8 more authors..  (2004)  Relevance of CD6-mediated interactions in T cell activation and proliferation..  Journal of immunology (Baltimore, Md. : 1950),  (15): [PMID:15294938]
13. Arnett, Kelly L KL, Harrison, Stephen C SC and Wiley, Don C DC..  (2004)  Crystal structure of a human CD3-epsilon/delta dimer in complex with a UCHT1 single-chain antibody fragment..  Proceedings of the National Academy of Sciences of the United States of America,  (16): [PMID:15534202]
14. Gaglia, Jason and Kissler, Stephan..  (2019)  Anti-CD3 Antibody for the Prevention of Type 1 Diabetes: A Story of Perseverance..  Biochemistry,  (8): [PMID:31523950]
15. Clevers, H C HC, Dunlap, S S, Wileman, T E TE and Terhorst, C C..  (1988)  Human CD3-epsilon gene contains three miniexons and is transcribed from a non-TATA promoter..  Proceedings of the National Academy of Sciences of the United States of America,  [PMID:3267235]
16. Fütterer, K K, Wong, J J, Grucza, R A RA, Chan, A C AC and Waksman, G G..  (1998)  Structural basis for Syk tyrosine kinase ubiquity in signal transduction pathways revealed by the crystal structure of its regulatory SH2 domains bound to a dually phosphorylated ITAM peptide..  Journal of molecular biology,  (21): [PMID:9698567]
17. Chen, X X, Ji, Z L ZL and Chen, Y Z YZ..  (2002)  TTD: Therapeutic Target Database..  Nucleic acids research,  (1): [PMID:11752352]

溶液计算器